EarningsQ2 2022 Earnings Report

Evelo Biosciences (EVLO) Q2 2022 Earnings Report

211 Followers

EVLO Q2 2022 EPS Results

Actual EPS-$8.00

Consensus EPS-$8.27

Beat/MissBeat by +$0.27

One Year Ago EPS-$11.80

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2022

Date08/11/2022

TimeBefore Open

Conference CallThursday, August 11, 2022

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Aug 01, 2024	2024 (Q2)	- / -	-3.78	―
May 30, 2024	2024 (Q1)	- / -	-4.585	―
Feb 15, 2024	2023 (Q4)	-1.27 / -	-4.2	―
Nov 02, 2023	2023 (Q3)	-1.07 / -0.71	-5.6	87.30% (+4.89)
Aug 14, 2023	2023 (Q2)	-3.26 / -3.78	-8	52.75% (+4.22)
Jun 01, 2023	2023 (Q1)	-3.65 / -4.60	-11.2	58.93% (+6.60)
Mar 16, 2023	2022 (Q4)	-5.50 / -4.20	-10.8	61.11% (+6.60)
Nov 14, 2022	2022 (Q3)	-6.33 / -5.60	-12.6	55.56% (+7.00)
Aug 11, 2022	2022 (Q2)	-8.27 / -8.00	-11.8	32.20% (+3.80)
May 12, 2022	2022 (Q1)	-11.28 / -11.20	-9.712	-15.32% (-1.49)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed